Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity - Concepedia

Concepedia

Publication | Open Access

Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity

DOI Full Paper Access

197

Citations

57

References

2021

Year

Daisy A. Hoagland, Rasmus Møller, Skyler Uhl, Kohei Oishi, Justin J. Frere, Ilona Golynker, Shu Horiuchi, Maryline Panis, Daniel Blanco-Melo, David Sachs,

MedicineFirst LineImmunologyViral PathogenesisAntiviral TherapyVirologyAntiviral ResponseAntiviral TypeVirus-host InteractionInfection ControlVirus TransmissionSars-cov-2 PathogenicityViral ImmunityCovid-19

References

	Year	Citations

Page 1

Page 1